Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Wilms' tumor suppressor gene wt1 encodes a zinc finger-containing protein that binds to the same DNA sequence as Egr-1, a mitogen-inducible immediate-early gene product that activates transcription. In this study, we investigated whether the human insulin-like growth factor-II (IGF-II) P4 promoter might be a target for transcriptional repression mediated by
WT1
. Using constructs of the IGF-II P4 promoter linked to the
chloramphenicol acetyltransferase
gene, we have demonstrated that the WT1 protein represses expression of the IGF-II gene through a GCGGGGGAG response element spanning nucleotides -87 to -65 of the IGF-II P4 promoter. Conversely, we have shown that the Egr-1 activates transcription of the IGF-II gene through the same response element.
WT1
and Egr-1 proteins interact directly with the
WT1
/Egr-1 response element of the IGF-II promoter 4 in gel mobility-shift assays. These findings demonstrate the importance of the
WT1
/Egr-1 consensus element for the expression of the IGF-II gene in response to positive or negative transcription signals.
...
PMID:Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1. 863 46
Midkine (MK) is a heparin-binding growth factor which is strongly expressed during the midgestation period of mouse embryogenesis. Wilms' tumor is an embryonal kidney malignancy in infants, and
WT1
has been identified as its tumor suppressor gene. The high expression level of MK in all Wilms' tumor specimens so far examined and the presence of two
WT1
elements (5'-GCGGGGGCG-3') in the human MK promoter region led us to examine the possible role of the
WT1
gene product in the regulation of MK gene expression. A gel shift assay verified the complex formation between the
WT1
gene product and
WT1
consensus sequence of MK gene. DNase1 footprint analysis also demonstrated that the downstream
WT1
element was protected from DNase1 cleavage by the addition of the WT1 protein. The human MK promoter fused with the
chloramphenicol acetyltransferase
gene (phMK2.3kCAT) was co-transfected with an effector plasmid containing the
WT1
gene into several cell lines. Transient transfection assays showed suppression of the MK promoter by
WT1
co-transfection in recipient cells; deletion of the
WT1
binding site abolished the suppression. The evidence reported in this study indicates that MK gene is a newly identified
WT1
target gene.
...
PMID:Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1). 895 Sep 87